Unidad de Medicina Experimental, Facultad de Medicina, Universidad Nacional Autónoma de México, Ciudad de México, México; Michael Smith Laboratories, University of Brithish Columbia, Vancouver, Canada.
Unidad de Medicina Experimental, Facultad de Medicina, Universidad Nacional Autónoma de México, Ciudad de México, México.
Arch Med Res. 2017 Nov;48(8):690-700. doi: 10.1016/j.arcmed.2017.11.015. Epub 2017 Dec 28.
The human gut is a highly complex ecosystem with an extensive microbial community, and the influence of the intestinal microbiota reaches the entire host organism. For example, the microbiome regulates fat storage, stimulates or renews epithelial cells, and influences the development and maturation of the brain and the immune system. Intestinal microbes can protect against infection by pathogenic bacteria, viruses, fungi and parasites. Hence, the maintenance of homeostasis between the gut microbiota and the rest of the body is crucial for health, with dysbiosis affecting disease. This review focuses on intestinal protozoa, especially those still representing a public health problem in Mexico, and their interactions with the microbiome and the host. The decrease in prevalence of intestinal helminthes in humans left a vacant ecological niche that was quickly occupied by protozoa. Although the mechanisms governing the interaction between intestinal microbiota and protozoa are poorly understood, it is known that the composition of the intestinal bacterial populations modulates the progression of protozoan infection and the outcome of parasitic disease. Most reports on the complex interactions between intestinal bacteria, protozoa and the immune system emphasize the protective role of the microbiota against protozoan infection. Insights into such protection may facilitate the manipulation of microbiota components to prevent and treat intestinal protozoan infections. Here we discuss recent findings about the immunoregulatory effect of intestinal microbiota with regards to intestinal colonization by protozoa, focusing on infections by Entamoeba histolytica, Blastocystis spp, Giardia duodenalis, Toxoplasma gondii and Cryptosporidium parvum. The possible consequences of the microbiota on parasitic, allergic and autoimmune disorders are also considered.
人类肠道是一个高度复杂的生态系统,拥有广泛的微生物群落,肠道微生物群的影响可触及整个宿主生物体。例如,微生物组调节脂肪储存,刺激或更新上皮细胞,并影响大脑和免疫系统的发育和成熟。肠道微生物可以防止致病菌、病毒、真菌和寄生虫的感染。因此,维持肠道微生物群与身体其他部分之间的平衡对于健康至关重要,而微生态失调会影响疾病。本综述重点介绍肠道原生动物,特别是那些在墨西哥仍构成公共卫生问题的原生动物,以及它们与微生物组和宿主的相互作用。人类肠道蠕虫感染率的下降留下了一个空的生态位,很快被原生动物占据。尽管肠道微生物群与原生动物相互作用的机制尚不清楚,但已知肠道细菌种群的组成可调节原生动物感染的进展和寄生虫病的结局。大多数关于肠道细菌、原生动物和免疫系统之间复杂相互作用的报告都强调了微生物群对原生动物感染的保护作用。深入了解这种保护作用可能有助于操纵微生物群成分,以预防和治疗肠道原生动物感染。在这里,我们讨论了关于肠道微生物群对肠道原生动物定植的免疫调节作用的最新发现,重点关注溶组织内阿米巴、蓝氏贾第鞭毛虫、十二指肠贾第鞭毛虫、刚地弓形虫和微小隐孢子虫的感染。还考虑了微生物群对寄生虫、过敏和自身免疫性疾病的可能影响。